Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.57 Million SEK | 37.55% |
| 2022 | 1.14 Million SEK | 35.66% |
| 2021 | 844 Thousand SEK | 133.15% |
| 2020 | 362 Thousand SEK | 1.69% |
| 2019 | 356 Thousand SEK | 6.91% |
| 2018 | 333 Thousand SEK | 123.55% |
| 2017 | 148.96 Thousand SEK | -15.97% |
| 2016 | 177.28 Thousand SEK | -13.6% |
| 2015 | 205.19 Thousand SEK | -42.87% |
| 2014 | 359.16 Thousand SEK | -69.53% |
| 2013 | 1.17 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 85 Thousand SEK | -45.51% |
| 2024 Q1 | 156 Thousand SEK | 0.0% |
| 2023 Q3 | 488 Thousand SEK | 18.45% |
| 2023 Q4 | 156 Thousand SEK | -68.03% |
| 2023 FY | 1.57 Million SEK | 37.55% |
| 2023 Q1 | 520 Thousand SEK | 3.59% |
| 2023 Q2 | 412 Thousand SEK | -20.77% |
| 2022 Q3 | 358 Thousand SEK | 247.57% |
| 2022 Q2 | 103 Thousand SEK | -43.41% |
| 2022 Q1 | 182 Thousand SEK | -40.33% |
| 2022 FY | 1.14 Million SEK | 35.66% |
| 2022 Q4 | 502 Thousand SEK | 40.22% |
| 2021 Q1 | 123 Thousand SEK | -19.08% |
| 2021 Q3 | 377 Thousand SEK | 892.11% |
| 2021 Q2 | 38 Thousand SEK | -69.11% |
| 2021 FY | 844 Thousand SEK | 133.15% |
| 2021 Q4 | 305 Thousand SEK | -19.1% |
| 2020 Q1 | 14 Thousand SEK | -68.89% |
| 2020 Q2 | 159 Thousand SEK | 1035.71% |
| 2020 Q3 | 37 Thousand SEK | -76.73% |
| 2020 Q4 | 152 Thousand SEK | 310.81% |
| 2020 FY | 362 Thousand SEK | 1.69% |
| 2019 Q4 | 45 Thousand SEK | -51.09% |
| 2019 Q1 | 66 Thousand SEK | -27.94% |
| 2019 Q3 | 92 Thousand SEK | -40.26% |
| 2019 Q2 | 154 Thousand SEK | 133.33% |
| 2019 FY | 356 Thousand SEK | 6.91% |
| 2018 Q2 | 44 Thousand SEK | -60.71% |
| 2018 Q1 | 112 Thousand SEK | 315.38% |
| 2018 Q3 | 85 Thousand SEK | 93.18% |
| 2018 Q4 | 91.59 Thousand SEK | 7.76% |
| 2018 FY | 333 Thousand SEK | 123.55% |
| 2017 Q2 | 68 Thousand SEK | 142.86% |
| 2017 Q3 | 27 Thousand SEK | -60.29% |
| 2017 Q4 | 26.96 Thousand SEK | -0.14% |
| 2017 FY | 148.96 Thousand SEK | -15.97% |
| 2017 Q1 | 28 Thousand SEK | -73.66% |
| 2016 Q4 | 106.28 Thousand SEK | 2025.68% |
| 2016 Q3 | 5000.00 SEK | -92.42% |
| 2016 Q2 | 66 Thousand SEK | -98.73% |
| 2016 Q1 | 5.18 Million SEK | 3.43% |
| 2016 FY | 177.28 Thousand SEK | -13.6% |
| 2015 Q2 | 3.48 Million SEK | 0.0% |
| 2015 Q3 | 5.01 Million SEK | 44.1% |
| 2015 Q4 | 5.01 Million SEK | 0.0% |
| 2015 FY | 205.19 Thousand SEK | -42.87% |
| 2015 Q1 | 3.48 Million SEK | 2615.34% |
| 2014 Q4 | 128.21 Thousand SEK | 0.0% |
| 2014 FY | 359.16 Thousand SEK | -69.53% |
| 2014 Q1 | 51.36 Thousand SEK | 0.0% |
| 2014 Q2 | 51.36 Thousand SEK | 0.0% |
| 2014 Q3 | 128.21 Thousand SEK | 149.61% |
| 2013 FY | 1.17 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -72.508% |
| Arrayit Corporation | 4.37 Million USD | 64.019% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 93.909% |
| Bioqual, Inc. | 58.59 Million USD | 97.312% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 89.703% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.979% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 75.26% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -49.773% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 96.083% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -251.956% |
| InVitro International | 792.62 Thousand USD | -98.706% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 85.85% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 78.198% |
| NovelStem International Corp. | 12 Thousand USD | -13025.0% |
| Optigenex Inc. | 465.97 Thousand USD | -238.005% |
| PharmChem, Inc. | 6.01 Million USD | 73.804% |
| Proteome Sciences plc | 6.4 Million USD | 75.393% |
| Response Genetics, Inc | 18.04 Million USD | 91.269% |
| Rennova Health, Inc. | 13.03 Million USD | 87.918% |
| RushNet, Inc. | 1.78 Million USD | 11.907% |
| ScreenPro Security Inc. | 1.91 Million USD | 17.716% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | 58.499% |
| Todos Medical Ltd. | 7.69 Million USD | 79.532% |